Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 6Observational 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 2229Neoplasms 2031Lung Neoplasms 1094Colorectal Neoplasms 1033Prostatic Neoplasms 892Carcinoma, Non-Small-Cell Lung 751Carcinoma, Hepatocellular 672Stomach Neoplasms 606Pancreatic Neoplasms 599Head and Neck Neoplasms 433Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Urinary Bladder Neoplasms 289Leukemia, Myeloid, Acute 276Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 251Disease 241Recurrence 225Glioma 217Carcinoma, Renal Cell 207

Interventions

Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Observational × Pancreatic Cancer Resectable × Clear all
NCT07157605 2025-09-05

SPLENDID

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Recruiting
94 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

NCT06809374 2025-02-05

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Kochi University

Completed
100 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

NCT04736043 2021-02-03

Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid

Samsung Medical Center

Unknown
300 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡